Methods of determining β-III tubulin expression
US8298512B2 · kind B2 · utility
2Cited by
10References
15Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 20, 2006 |
| Grant date | Oct 30, 2012 |
| Priority date | — |
| Expiry date | May 2, 2030 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are methods of determining the quantity and location of βIII-tubulin expression in a subject, which may be used to determine the location and/or extent of excessive or uncontrolled growth of cells such as tumors. Such methods may include administering at least one compound to a patient and determining the quantity and location of βIII tubulin expression within the patient by visualizing the compound within the patient. Visualization of the compound may be indicative of the binding of the compound to cells that are actively expressing βIII tubulin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.